| 1 | 1.5 x 10^6 UC-MSC + CM | - | - | - | - | [1] 90 90 💬
|
| 2 | 100 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 3 | 100 µg KIO-301 | [1] KIO-301 KIO-301 | - | - | - | [1] 90 90 💬
|
| 4 | 200 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 5 | 400 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 6 | 4D-125 IVT Injection | - | - | - | - | [1] 90 90 💬
|
| 7 | 5 x 10^6 UC-MSC + CM | - | - | - | - | [1] 90 90 💬
|
| 8 | 50 µg KIO-301 | [1] KIO-301 KIO-301 | - | - | - | [1] 90 90 💬
|
| 9 | 5081 | - | - | - | - | [1] 90 90 💬
|
| 10 | 9-cis beta-Carotene-rich extract of Dunaliella alga | - | - | - | - | [1] 90 90 💬
|
| 11 | 9715X | - | - | - | - | [1] 90 90 💬
|
| 12 | 9741X | - | - | - | - | [1] 90 90 💬
|
| 13 | 9742X | - | - | - | - | [1] 90 90 💬
|
| 14 | [Dual AAV8.MYO7A] | - | - | - | - | [2] 90 90, 303 💬
|
| 15 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 16 | [Prednisone] | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 19 19, 66, 90, 300, 303 💬
|
| 17 | AAV2-REP1 | - | - | - | - | [1] 90 90 💬
|
| 18 | AAV2/5-hPDE6B | - | - | - | - | [1] 90 90 💬
|
| 19 | AAV2/5-hRKp.RPGR | - | - | - | - | [1] 90 90 💬
|
| 20 | AAV5-HRKP.RPGR | [1] Botaretigene sparoparvovec Botaretigene sparoparvovec | - | - | - | [1] 90 90 💬
|
| 21 | AAV8-RPGR | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | [1] 90 90 💬
|
| 22 | AAVB-081 | - | - | - | - | [2] 90 90, 303 💬
|
| 23 | ACDN-01 | - | - | - | - | [2] 90 90, 301 💬
|
| 24 | ACE Retino | - | - | - | - | [1] 90 90 💬
|
| 25 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 26 | Acetazolamide | [1] Acetazolamide Acetazolamide | [2] Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| [13] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| [6] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | [8] 13 13, 67, 90, 115, 155, 222, 225, 230 💬
|
| 27 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 28 | Acetylcysteine amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 29 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 30 | Adeno-associated virus type 2 vector encoding Rab escort protein 1 | - | - | - | - | [1] 90 90 💬
|
| 31 | Adeno-associated virus vector expressing a human RPGR gene | - | - | - | - | [1] 90 90 💬
|
| 32 | ADX-2191 | - | - | - | - | [1] 90 90 💬
|
| 33 | Aflibercept | [1] Aflibercept Aflibercept | [1] Aflibercept
Aflibercept
💬
| [3] PGF PGF, VEGFA, VEGFB 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [2] 90 90, 166 💬
|
| 34 | AGN-151597 | - | - | - | - | [1] 90 90 💬
|
| 35 | AGTC-501 (high dose and modified corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 36 | AGTC-501 (high dose and standard corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 37 | AGTC-501 (low dose and standard corticosteroid regimen) | - | - | - | - | [1] 90 90 💬
|
| 38 | Alga Dunaliella Bardawil | - | - | - | - | [1] 90 90 💬
|
| 39 | Alga Dunaliella Bardawil powder | - | - | - | - | [1] 90 90 💬
|
| 40 | Alga Dunaliella Bardawill | - | - | - | - | [1] 90 90 💬
|
| 41 | ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED | - | - | - | - | [1] 90 90 💬
|
| 42 | AlloRx | - | - | - | - | [8] 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
| 43 | Amino acids | [1] Amino acids Amino acids | - | - | - | [6] 6 6, 70, 90, 113, 240, 298 💬
|
| 44 | Antioxidants | - | - | - | - | [3] 90 90, 298, 310 💬
|
| 45 | Aprokam | - | - | - | - | [1] 90 90 💬
|
| 46 | BETAMETASONE | - | - | - | - | [1] 90 90 💬
|
| 47 | BETAMETASONE DOC | - | - | - | - | [1] 90 90 💬
|
| 48 | Betamethasone | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 2 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
|
| 49 | BIIB112 | - | - | - | - | [1] 90 90 💬
|
| 50 | Blue light-absorbing sunglasses | - | - | - | - | [1] 90 90 💬
|
| 51 | BMMNCs | - | - | - | - | [1] 90 90 💬
|
| 52 | Botaretigene Sparoparvovec | [1] Botaretigene sparoparvovec Botaretigene sparoparvovec | - | - | - | [1] 90 90 💬
|
| 53 | Brimonidine | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 💬
|
| 54 | Brimonidine tartrate | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 💬
|
| 55 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | [1] Brimonidine Brimonidine | [2] Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 56 | BS01 | - | - | - | - | [1] 90 90 💬
|
| 57 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 58 | Cannabis | - | - | - | - | [2] 13 13, 90 💬
|
| 59 | CARBIDOPA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [7] 6 6, 13, 17, 90, 140, 164, 201 💬
|
| 60 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | [1] 90 90 💬
|
| 61 | CEFAZOLINA | - | - | - | - | [1] 90 90 💬
|
| 62 | Cefazolina Qilu | - | - | - | - | [1] 90 90 💬
|
| 63 | CEFUROXIMA | - | - | - | - | [1] 90 90 💬
|
| 64 | Cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [10] 8 8, 19, 71, 79, 90, 160, 222, 259, 261, 310 💬
|
| 65 | Ciliary Neurotrophic Factor Implant NT-501 | - | - | - | - | [1] 90 90 💬
|
| 66 | Circadin 2 mg | - | - | - | - | [1] 90 90 💬
|
| 67 | CIRCADIN 2 mg comprimidos de liberación prolongada | - | - | - | - | [1] 90 90 💬
|
| 68 | CLORAMFENICOLO | - | - | - | - | [1] 90 90 💬
|
| 69 | Cloramfenicolo Fisiopharma | - | - | - | - | [1] 90 90 💬
|
| 70 | CLORAMFENICOLO FISIOPHARMA - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE DA 10 ML | - | - | - | - | [1] 90 90 💬
|
| 71 | CNS10-NPC implantation | - | - | - | - | [1] 90 90 💬
|
| 72 | CNTO 2476 | - | - | - | - | [1] 90 90 💬
|
| 73 | Combination Product: Gene therapy: GS030-DP AND Medical device: GS030-MD | [1] GS030-DP GS030-DP | - | - | - | [1] 90 90 💬
|
| 74 | Combination Product: PRP combined Magnovision | - | - | - | - | [1] 90 90 💬
|
| 75 | Compound thrombosis capsule sig: 1.5g/tid | - | - | - | - | [1] 90 90 💬
|
| 76 | Conditioned Medium (CM) | - | - | - | - | [1] 90 90 💬
|
| 77 | Continuous oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 90 90 💬
|
| 78 | Control | - | - | - | - | [8] 2 2, 6, 46, 51, 90, 97, 168, 299 💬
|
| 79 | COQUN | - | - | - | - | [1] 90 90 💬
|
| 80 | Cornstarch control | - | - | - | - | [1] 90 90 💬
|
| 81 | Cotoretigene Toliparvovec | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | [1] 90 90 💬
|
| 82 | CPK850 | - | - | - | - | [1] 90 90 💬
|
| 83 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 84 | Cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [13] 6 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
|
| 85 | DESAMETASONE | - | - | - | - | [3] 28 28, 63, 90 💬
|
| 86 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 87 | Dexamethasone injection | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 88 | Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) | - | - | - | - | [2] 90 90, 301 💬
|
| 89 | Disulfiram | [1] Disulfiram Disulfiram | [1] Disulfiram
Disulfiram
💬
| [3] ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| [13] Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [3] 46 46, 90, 301 💬
|
| 90 | Docosahexaenoic acid | - | - | - | - | [4] 49 49, 90, 240, 299 💬
|
| 91 | Dorzolamide | [1] Dorzolamide Dorzolamide | [2] Dorzolamide hydrochloride
Dorzolamide hydrochloride
,
Dorzolamide
💬
| [13] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| [6] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | [1] 90 90 💬
|
| 92 | DSP-3077 Retinal Sheet Cohort 1 | - | - | - | - | [1] 90 90 💬
|
| 93 | DSP-3077 Retinal Sheet Cohort 2 | - | - | - | - | [1] 90 90 💬
|
| 94 | DSP-3077 Retinal Sheet Cohort 3 | - | - | - | - | [1] 90 90 💬
|
| 95 | Dual AAV8.MYO7A | - | - | - | - | [2] 90 90, 303 💬
|
| 96 | Ducressa | - | - | - | - | [1] 90 90 💬
|
| 97 | EA-2353 | [1] EA-2353 EA-2353 | - | - | - | [1] 90 90 💬
|
| 98 | Eylea | - | - | - | - | [2] 90 90, 166 💬
|
| 99 | Fluocinolone | [1] Fluocinolone Fluocinolone | - | - | - | [1] 90 90 💬
|
| 100 | Fluocinolone Acetonide | [2] Fluocinolone Fluocinolone, Fluocinolone acetonide | [1] Fluocinolone acetonide
Fluocinolone acetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 101 | Gene Therapy Product-MCO-010 | - | - | - | - | [2] 90 90, 301 💬
|
| 102 | Gene Therapy product:vMCO-I | - | - | - | - | [1] 90 90 💬
|
| 103 | Genetic: AAV2/5-RPGR | - | - | - | - | [1] 90 90 💬
|
| 104 | Genetic: AAV5-hRKp.RPGR | - | - | - | - | [1] 90 90 💬
|
| 105 | Genetic: AAV5-hRKp.RPGR Intermediate Dose | - | - | - | - | [1] 90 90 💬
|
| 106 | Genetic: AAV5-hRKp.RPGR Low Dose | - | - | - | - | [1] 90 90 💬
|
| 107 | Genetic: BIIB111 | - | - | - | - | [1] 90 90 💬
|
| 108 | Genetic: BIIB112 | - | - | - | - | [1] 90 90 💬
|
| 109 | Genetic: Blood and/or skin biopsy | - | - | - | - | [2] 90 90, 301 💬
|
| 110 | Genetic: FT-002 | - | - | - | - | [1] 90 90 💬
|
| 111 | Genetic: genetic analysis | - | - | - | - | [8] 34 34, 85, 90, 93, 94, 96, 234, 265 💬
|
| 112 | Genetic: Genetic Testing | - | - | - | - | [5] 79 79, 89, 90, 158, 299 💬
|
| 113 | Genetic: RTx-015 | - | - | - | - | [1] 90 90 💬
|
| 114 | Genetic: Sub-Retinal Administration of OCU400-301 | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 115 | Genetic: UGX202 injection | - | - | - | - | [1] 90 90 💬
|
| 116 | Genetic: ZM-02 (high dose) | - | - | - | - | [1] 90 90 💬
|
| 117 | Genetic: ZM-02 (low dose) | - | - | - | - | [1] 90 90 💬
|
| 118 | Genetic: ZM-02 (selected dose) | - | - | - | - | [1] 90 90 💬
|
| 119 | Ginkgo biloba | [1] Ginkgo biloba Ginkgo biloba | [1] Ginkgo
Ginkgo
💬
| - | - | [4] 13 13, 18, 47, 90 💬
|
| 120 | Ginkgo biloba pills sig: 300mg/tid | [1] Ginkgo biloba Ginkgo biloba | [1] Ginkgo
Ginkgo
💬
| - | - | [1] 90 90 💬
|
| 121 | GMP compliant-BM-MSC derived sEVs | - | - | - | - | [1] 90 90 💬
|
| 122 | GS030-DP | [1] GS030-DP GS030-DP | - | - | - | [1] 90 90 💬
|
| 123 | HORA-PDE6B (AAV2/5.hPDE6B) | - | - | - | - | [1] 90 90 💬
|
| 124 | HRPC | - | - | - | - | [1] 90 90 💬
|
| 125 | HRPC DP | - | - | - | - | [1] 90 90 💬
|
| 126 | Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) | - | - | - | - | [1] 90 90 💬
|
| 127 | Human primary Retinal Pigment Epithelial (HuRPE) cells | - | - | - | - | [1] 90 90 💬
|
| 128 | Human retinal progenitor cells | - | - | - | - | [1] 90 90 💬
|
| 129 | Human Retinal Progenitor Cells Drug Product | - | - | - | - | [1] 90 90 💬
|
| 130 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 131 | Hydroxychloroquine higher dose | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 90 90 💬
|
| 132 | Hydroxychloroquine lower dose | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 90 90 💬
|
| 133 | Hyperbaric Oxygen Therapy | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [2] 71 71, 90 💬
|
| 134 | IGT001 | - | - | - | - | [1] 90 90 💬
|
| 135 | Iluvien | - | - | - | - | [1] 90 90 💬
|
| 136 | Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa | - | - | - | - | [1] 90 90 💬
|
| 137 | Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa | - | - | - | - | [1] 90 90 💬
|
| 138 | Intravitreal Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 90 90 💬
|
| 139 | Intravitreal autologous CD34+ cells | - | - | - | - | [1] 90 90 💬
|
| 140 | Intravitreal injection of Autologous bone marrow Stem Cell | - | - | - | - | [1] 90 90 💬
|
| 141 | Intravitreal injection of autologous bone marrow stem cells | - | - | - | - | [1] 90 90 💬
|
| 142 | Intravitreal Injection of Ultevursen | [1] Ultevursen Ultevursen | - | - | - | [2] 90 90, 303 💬
|
| 143 | ISTEM-01 | - | - | - | - | [1] 90 90 💬
|
| 144 | KENACORT | - | - | - | - | [2] 90 90, 96 💬
|
| 145 | KENACORT - 40 MG/ ML SOSPENSIONE INIETTABILE 3 FLACONCINI DA 1 ML | - | - | - | - | [1] 90 90 💬
|
| 146 | KIO-301 | [1] KIO-301 KIO-301 | - | - | - | [1] 90 90 💬
|
| 147 | Lentiviral vector containing MYO7A gene | - | - | - | - | [2] 90 90, 303 💬
|
| 148 | Lentiviral vector containing the human MY07A gene | - | - | - | - | [2] 90 90, 303 💬
|
| 149 | Levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [8] 5 5, 6, 17, 90, 120, 140, 164, 201 💬
|
| 150 | Levodopa-Carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 90 💬
|
| 151 | Lutein | [1] Lutein Lutein | - | - | - | [3] 13 13, 90, 164 💬
|
| 152 | Lutein (10 or 30 mg/day) capsules | [1] Lutein Lutein | - | - | - | [1] 90 90 💬
|
| 153 | Lycium Barbarum | - | - | - | - | [1] 90 90 💬
|
| 154 | Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 155 | Minocycline | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [14] 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
| 156 | Minocycline 100mg | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [2] 13 13, 90 💬
|
| 157 | Minocycline 200mg | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [1] 90 90 💬
|
| 158 | N-Acetyl Cysteine (NAC) | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [1] 90 90 💬
|
| 159 | N-Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [14] 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
| 160 | N-Acetylcysteine Amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 161 | NAC effervescent tablets | - | - | - | - | [1] 90 90 💬
|
| 162 | Nerve Growt Factor - 2.5S | - | - | - | - | [1] 90 90 💬
|
| 163 | Nerve Growth Factor | [1] Nerve Growth Factor Nerve Growth Factor | - | - | - | [5] 2 2, 3, 18, 53, 90 💬
|
| 164 | Nilvadipine | [1] Nilvadipine Nilvadipine | [1] Nilvadipine
Nilvadipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 165 | NL-FLVC-001 | - | - | - | - | [1] 90 90 💬
|
| 166 | NPI-001 | - | - | - | - | [2] 90 90, 303 💬
|
| 167 | NT-501 | - | - | - | - | [2] 90 90, 303 💬
|
| 168 | Nutritional Supplement | - | - | - | - | [1] 90 90 💬
|
| 169 | OCU400 | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 170 | OCU400 High Dose | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 171 | OCU400 Low Dose | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 172 | OCU400 Med Dose | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 173 | OCU400 Second Eye Dosing | [1] OCU400 OCU400 | - | - | - | [1] 90 90 💬
|
| 174 | Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [18] 6 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
|
| 175 | OpCT-001 | - | - | - | - | [3] 90 90, 301, 303 💬
|
| 176 | Oral disulfiram | [1] Disulfiram Disulfiram | [1] Disulfiram
Disulfiram
💬
| [3] ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| [13] Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 90 90, 301 💬
|
| 177 | Other: Mock injection | - | - | - | - | [1] 90 90 💬
|
| 178 | Other: No intervention (Follow-Up assessment) | - | - | - | - | [1] 90 90 💬
|
| 179 | Other: No intervention, will not receive any active study intervention | - | - | - | - | [2] 90 90, 303 💬
|
| 180 | Other: Observational | - | - | - | - | [1] 90 90 💬
|
| 181 | Other: Sham (no implant) | - | - | - | - | [1] 90 90 💬
|
| 182 | Other: Sham procedure | - | - | - | - | [1] 90 90 💬
|
| 183 | Other: Sham-procedure | - | - | - | - | [2] 90 90, 303 💬
|
| 184 | Other: Sham-procedure (dose cohort 1&2 only) | - | - | - | - | [2] 90 90, 303 💬
|
| 185 | Other: Standard of Care Sildenafil | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 90 90, 301 💬
|
| 186 | Other: Subconjunctival injection of saline | - | - | - | - | [1] 90 90 💬
|
| 187 | Other: Sugar pill | - | - | - | - | [1] 90 90 💬
|
| 188 | Other: Visual Acuity (VA) | - | - | - | - | [2] 90 90, 301 💬
|
| 189 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 190 | Phase 1a: OCT-980 Capsule | - | - | - | - | [1] 90 90 💬
|
| 191 | Phase 1b/2: OCT-980 Tablet | - | - | - | - | [1] 90 90 💬
|
| 192 | Pitavastatin | [1] Pitavastatin Pitavastatin | [2] Pitavastatin calcium
Pitavastatin calcium
,
Pitavastatin magnesium
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [4] 49 49, 71, 79, 90 💬
|
| 193 | Platelet Rich Plasma | [1] Platelet Rich Plasma Platelet Rich Plasma | - | - | - | [6] 35 35, 46, 47, 70, 90, 269 💬
|
| 194 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 195 | PREDNISONE DOC GENERICI | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 196 | Prescribe N-acetylcysteine tablets | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 90 90 💬
|
| 197 | PRP | - | - | - | - | [1] 90 90 💬
|
| 198 | QLT091001 | - | - | - | - | [1] 90 90 💬
|
| 199 | QR-1123 | [1] QR-1123 QR-1123 | - | - | - | [1] 90 90 💬
|
| 200 | QR-421a | - | - | - | - | [2] 90 90, 303 💬
|
| 201 | RAAV.hPDE6A vector Pharmaceutical Form: Concentrate for solution for injection | - | - | - | - | [1] 90 90 💬
|
| 202 | RAAV2tYF-GRK1-hRPGRco | - | - | - | - | [1] 90 90 💬
|
| 203 | RAAV2tYF-GRK1-RPGR | - | - | - | - | [1] 90 90 💬
|
| 204 | Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene | - | - | - | - | [1] 90 90 💬
|
| 205 | RECOMBINANT HUMAN NERVE GROWTH FACTOR (RHNGF) | [1] Nerve Growth Factor Nerve Growth Factor | - | - | - | [1] 90 90 💬
|
| 206 | Retinal pigment epitheliums transplantation | - | - | - | - | [1] 90 90 💬
|
| 207 | RhNGF 180 µg/ml eye drops solution | - | - | - | - | [1] 90 90 💬
|
| 208 | RhNGF 60 µg/ml eye drops solution | - | - | - | - | [1] 90 90 💬
|
| 209 | RNA antisense oligonucleotide for intravitreal injection | - | - | - | - | [2] 90 90, 303 💬
|
| 210 | SAR421869 | [1] SAR421869 SAR421869 | - | - | - | [2] 90 90, 303 💬
|
| 211 | Sham | - | - | - | - | [4] 90 90, 211, 301, 303 💬
|
| 212 | Sham Injection | - | - | - | - | [2] 90 90, 302 💬
|
| 213 | Sildenafil | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 214 | SPVN06 | - | - | - | - | [2] 90 90, 301 💬
|
| 215 | Stem cell implantation | - | - | - | - | [1] 90 90 💬
|
| 216 | Stem Cell Transplantation | - | - | - | - | [14] 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 217 | Stem/progenitor cells transplantation | - | - | - | - | [2] 90 90, 301 💬
|
| 218 | Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus | - | - | - | - | [1] 90 90 💬
|
| 219 | Subretinal injection of rAAV.hPDE6A | - | - | - | - | [1] 90 90 💬
|
| 220 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | [1] 90 90 💬
|
| 221 | Subtenon Injection of Autologous Platelet-Rich Plasma | - | - | - | - | [1] 90 90 💬
|
| 222 | Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes | - | - | - | - | [1] 90 90 💬
|
| 223 | Subtenon injection of Wharton jelly derived mesenchymal stem cells | - | - | - | - | [1] 90 90 💬
|
| 224 | TBD | - | - | - | - | [5] 19 19, 86, 90, 276, 299 💬
|
| 225 | Timrepigene emparvovec | [1] Timrepigene emparvovec Timrepigene emparvovec | - | - | - | [1] 90 90 💬
|
| 226 | TOBRAMICINA E DESAMETASONE DOC Generici | - | - | - | - | [1] 90 90 💬
|
| 227 | TOBRAMICINA E DESAMETASONE DOC GENERICI - | - | - | - | - | [1] 90 90 💬
|
| 228 | Triamcinolone | [1] Triamcinolone Triamcinolone | [4] Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [11] 35 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬
|
| 229 | Twice-daily dosage with 0.5% cyclosporine-A eyedrops | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 230 | UF-021 | - | - | - | - | [1] 90 90 💬
|
| 231 | Ultevursen | [1] Ultevursen Ultevursen | - | - | - | [2] 90 90, 303 💬
|
| 232 | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | - | - | - | - | [1] 90 90 💬
|
| 233 | Unoprostone | [1] Unoprostone Unoprostone | [2] Isopropyl unoprostone
Isopropyl unoprostone
,
Unoprostone
💬
| [1] PTGFR PTGFR 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | [1] 90 90 💬
|
| 234 | UshStat | - | - | - | - | [2] 90 90, 303 💬
|
| 235 | UshStat (SAR421869) | [1] SAR421869 SAR421869 | - | - | - | [2] 90 90, 303 💬
|
| 236 | Valproic Acid | [1] Valproic acid Valproic acid | [3] Divalproex sodium
Divalproex sodium
,
Valproic acid
,
Valproate sodium
💬
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬
| [16] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [10] 3 3, 5, 26, 34, 65, 89, 90, 145, 222, 331 💬
|
| 237 | Vehicle eye drops | - | - | - | - | [1] 90 90 💬
|
| 238 | VG901 | - | - | - | - | [1] 90 90 💬
|
| 239 | Vitamin A | [1] Vitamin A Vitamin A | [2] Vitamin A oil
Vitamin A oil
,
Vitamin A
💬
| [2] RARA RARA, RARB 💬
| [8] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [4] 13 13, 53, 90, 97 💬
|
| 240 | Vitamin AD sig: 1 tablet/tid | - | - | - | - | [1] 90 90 💬
|
| 241 | Vitamin B sig: 10mg/tid | - | - | - | - | [1] 90 90 💬
|
| 242 | Vitamin E | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [12] 2 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
|
| 243 | VP-001 | - | - | - | - | [1] 90 90 💬
|
| 244 | Wharton's jelly derived mesenchymal stem cell | - | - | - | - | [1] 90 90 💬
|
| 245 | ZAPROL* | - | - | - | - | [1] 90 90 💬
|
| 246 | ZM-02-H | - | - | - | - | [1] 90 90 💬
|
| 247 | ZM-02-L | - | - | - | - | [1] 90 90 💬
|
| 248 | ZM-02-S | - | - | - | - | [1] 90 90 💬
|
| 249 | Zuretinol Acetate | [2] Acetate Acetate, Zuretinol acetate | - | - | - | [1] 90 90 💬
|
| 250 | ZVS203e | - | - | - | - | [1] 90 90 💬
|